Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125893492 | 12589349 | 2 | F | 2015 | 20160808 | 20160725 | 20160810 | EXP | FR-JNJFOC-20160717457 | JANSSEN | 40.97 | YR | A | F | Y | 0.00000 | 20160810 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125893492 | 12589349 | 1 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | N | 0 | 800 | MG | TABLETS | QD | ||||||
| 125893492 | 12589349 | 2 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | N | 21976 | 600 | MG | TABLETS | BID | ||||||
| 125893492 | 12589349 | 3 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 100 | MG | CAPSULE | QD | |||||||
| 125893492 | 12589349 | 4 | SS | NORVIR | RITONAVIR | 1 | Oral | 0 | 100 | MG | CAPSULE | BID | |||||||
| 125893492 | 12589349 | 5 | SS | AMOXICILLIN TRIHYDRATE | AMOXICILLIN | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
| 125893492 | 12589349 | 6 | SS | SMECTA | MONTMORILLONITE | 1 | Oral | U | 0 | POWDER | |||||||||
| 125893492 | 12589349 | 7 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125893492 | 12589349 | 1 | HIV infection |
| 125893492 | 12589349 | 2 | HIV infection |
| 125893492 | 12589349 | 3 | HIV infection |
| 125893492 | 12589349 | 4 | HIV infection |
| 125893492 | 12589349 | 5 | Product used for unknown indication |
| 125893492 | 12589349 | 6 | Product used for unknown indication |
| 125893492 | 12589349 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125893492 | 12589349 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125893492 | 12589349 | Exposure during pregnancy | |
| 125893492 | 12589349 | Polyhydramnios | |
| 125893492 | 12589349 | Viral load increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125893492 | 12589349 | 2 | 20160405 | 0 | ||
| 125893492 | 12589349 | 4 | 20160405 | 0 | ||
| 125893492 | 12589349 | 5 | 20160204 | 0 | ||
| 125893492 | 12589349 | 6 | 20160204 | 0 | ||
| 125893492 | 12589349 | 7 | 20160204 | 0 |